CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Dowling, Ryan JO
  • Parulekar, Wendy R
  • Gelmon, Karen A
  • Shepherd, Lois E
  • Virk, Shakeel
  • Ennis, Marguerite
  • Mao, Fangya
  • Ligibel, Jennifer A
  • Hershman, Dawn L
  • Rastogi, Priya
  • Mayer, Ingrid A
  • Hobday, Timothy J
  • Lemieux, Julie
  • Thompson, Alastair Mark
  • Rabaglio-Poretti, Manuela
  • Whelan, Timothy
  • Stambolic, Vuk
  • Chen, Bingshu E
  • Goodwin, Pamela Jean

publication date

  • May 20, 2018